- Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
- 6 dental technology updates in May
- From clinician to leader: Building confidence, capability and leadership in dentistry
- Operationalizing AI at scale: A practical framework for enterprise-scale success
- 3 key stats on the orthodontist workforce
- Meet the COOs of 10 specialty DSOs
- Data, cross-training, and pipeline development: How health systems are rethinking OR staffing
- How top health systems are redefining the digital patient experience
- ‘The most significant change in 20 years’: Cancer centers prepare for daraxonrasib demand
- A Smooth Handoff From Decision to Dollars: Connecting the Last Mile in Healthcare Payments
- Budget-Strapped Montana Will Stress-Test Trump’s Medicaid Work Rules
- How CEOs actually use hospital rankings — and when they don’t
- What OU Health’s founding CEO learned building a new health system
- Arkansas hospital CEO to step down after 11 years for new role
- The behavioral health workforce pipeline: Where it stands and where it’s headed
- 6 major investments in youth behavioral health
- Coalition for Health AI unveils governance playbook for systems
- 66 health systems ranked by long-term debt
- UnitedHealthcare drops some prior auth requirements for cardiology, orthopedic services
- 8 No Surprises Act shake-ups physicians need to know
- The ASC independence playbook: 3 leaders’ thoughts
- Dr. Rahimah Maina opens new dental practice
- GWU offloaded its $450M physician group problem — why the industry watching
- The gastroenterologist pay gap
- Texas surgery center to double in size, add 2 ORs
- What dental leaders told us in May
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- What’s going on at the FTC? 3 notes for ASC leaders
- 8 DSOs making headlines
- The physician noncompete battle in 5 key figures
- The physician red flags that can predict a bad ASC partner
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Nearly 70% of US counties lack a GI: 13 concerning workforce stats
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- A new behavioral health profession is born
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Dentists’ pay climbed the most in these 10 states
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Massachusetts AG sues UnitedHealthcare over alleged Medicaid fraud
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Weekly Rundown—Moffitt Cancer Center expands Reimagine Care's virtual oncology model; Tanner Health deploys AI workforce solution
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
- Aetna to launch ‘on demand’ virtual mental health services in 2027
- U of Connecticut dental school reappoints dean for 2nd term
- Michigan dentist charged with Medicaid fraud
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- Acadia in the headlines: 6 things to know
- 26 behavioral health executive moves to know
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Behavioral health hospital operator to pay $32M in Medicare fraud settlement
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- CVS expands partnership with Salesforce for greater call center personalization
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- Listen to the Latest ‘KFF Health News Minute’
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Teladoc Health inks partnership with Walmart to expand virtual care services
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Kaléo speaks up on allergy awareness to amplify patient stories
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- NYC Health + Hospitals adds 2nd behavioral health housing site
- Mindfulness isn’t a perk anymore — it’s a workforce strategy
- With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down
- Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- GoodRx launches subscription program for low-cost generic medications, telehealth services
- George Washington University locks deal to hand off debt-ridden physician practice to UHS
- Humana invests $83M in new Florida pharmacy distribution center
- As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey
- ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary
- An insider’s look at LillyDirect
- GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
- Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims
- FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
- Eli Lilly wins argument over Noom’s GLP-1 dosing claims
- Remarks at the Stanford Rock Center for Corporate Governance
- Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
- Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
- JD Power: Cost pressures worsen member experience with commercial plans
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Listen to the Latest ‘KFF Health News Minute’
- As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
- Radiopharmaceutical outfit Lantheus mulls potential $7B takeover by Curium: Bloomberg
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- SK bioscience links up with Colombia to enable local production of varicella vaccine
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Common Food Preservatives Linked to Major Heart Problems
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
The Michigan Department of Agriculture and Rural Development (MDARD) and MDHHS are warning against online purchases of unregistered pesticides containing organophosphate dichlorvos (DDVP), specifically “Sniper” and “Nopest”. These insecticides destroy nervous system functioning, just as military nerve gasses do. Neither Michigan department explains the meaning of registration in this joint press release, but I think they are referring to Agency for Toxic Substances and Disease Registry (ATSDR) registration:
https://www.michigan.gov/mdhhs/inside-mdhhs/newsroom/2026/02/09/ddvp-warning
https://www.michigan.gov/mdard/plant-pest/pesticides
MDHHS and MDARD urge residents to use caution when buying and using pesticides
By Lynn Sutfin - February 09, 2026Recent poisonings due to pesticides containing dichlorvos prompt warning
LANSING, Mich. – The Michigan Department of Health and Human Services (MDHHS) and Michigan Department of Agriculture and Rural Development (MDARD) are warning residents to avoid purchasing unregistered pesticides containing dichlorvos (DDVP), including brand names “Sniper” and “Nopest.”
Despite their potentially harmful health effects, “Sniper” and “Nopest” remain available for purchase via online marketplaces, where they are marketed as insecticides for home use. These and other pesticides that contain highly concentrated DDVP are responsible for recent poisonings in Michigan. Consumers should be aware that not all pesticides purchased online are registered by the U.S. Environmental Protection Agency (EPA) or are safe to use at home. Neither “Sniper” or “Nopest” are registered by EPA.
“These recent cases are a serious reminder that unregistered or illegal pesticide products can pose significant risks to public health,” said MDARD Director Tim Boring. “MDARD urges residents to take simple steps, such as checking for an EPA registration number and following label directions, to protect themselves, their families and the environment.”
Pesticides are any substance used to kill or repel pests to reduce the damage they cause. They include disinfectants, fungicides, insecticides, herbicides and animal repellants.
If you become sick after being exposed to pesticides, contact Poison Control at 800-222-1222 or call your health care provider. If you become severely ill or have a hard time breathing, call 911 or go to the emergency room.
“We urge Michigan residents to use precaution when using pesticides to prevent harm to themselves, their family or pets,” said Dr. Natasha Bagdasarian, chief medical executive. “If you suspect pesticide poisoning, move to fresh air, remove any contaminated clothing, wash skin with soap and water, and seek medical attention.”
Pesticide poisoning symptoms include:
- Eye, nose and/or throat irritation.
- Headache.
- Nausea.
- Seizures.
- Shortness of breath.
- Skin irritation.
- Coma.
- Death.
Risk of pesticide poisoning depends on the following:
- Toxicity.
- Length of exposure.
- Amount of pesticide.
- Type of exposure, such as breathing it in, getting it in the eyes or on the skin, or eating or drinking it.
To avoid serious injury or illness when using pesticides:
- Purchase pesticides with an EPA Registration Number (“EPA Reg. No.”) and an EPA Establishment Number (“EPA Est. No.”) on the label. These are tested to make sure they do not cause major risks to human health or the environment when used as directed.
- Read and follow the label. Following label directions is the only safe way to use a pesticide.
- Wear required protective clothing and equipment such as gloves, eye protection or masks.
- Do not spray pesticides outdoors when it is windy.
- Wipe, rather than spray, disinfectant products indoors.
- Wash hands and clothing after using pesticides.
- Store pesticides in a safe place away from children and pets.
Residents who discover they have unregistered pesticides in their possession should immediately dispose of these products using the following steps:
- Wear protective clothing, gloves and a face mask, and double bag the bottle or container in heavy plastic.
- Add sand, dirt or kitty litter to the bag, if possible, especially if the bottle is leaking.
- Contact the local waste management company to find out where to safely dispose of the container.
- Do not let children or pets near the pesticide.
- Do not pour the pesticide down the drain.
Pesticide poisoning in Michigan
Since 2001, there have been three confirmed unintentional pesticide-related deaths. While deaths from pesticides are rare, more than 2,700 total confirmed pesticide illnesses or injuries were reported in the past decade.
For more information about pesticides, visit:
MDHHS pesticide illness webpage
MDARD pesticides webpage
Pesticides are also a health issue at the national level, in the USDA "farm bill":
https://thehill.com/policy/energy-environment/5737733-farm-bill-pesticides-maha/
In farm bill, GOP takes another swing at pesticide protections loathed by MAHA
By Rachel Frazin - February 13, 2026Republicans are using the farm bill to take another swing at passing legislation to protect pesticides, something sure to anger their allies in the “Make America Healthy Again” (MAHA) movement.
A House Republican iteration of the farm bill released on Friday includes a provision that prevents states and courts from penalizing pesticide makers for failing to include warnings on their label about health effects that go beyond those formally recognized by the Environmental Protection Agency (EPA).
Proponents of such measures say they prevent companies from having to comply with a hodgepodge of rules that could differ from place to place.
However, opponents of such language argue that it could be used to tamp down on failure-to-warn lawsuits that seek to hold pesticide companies accountable for not disclosing alleged harms of their products.
Similar language was ultimately removed from an EPA appropriations package earlier this year amid pushback from Democrats and MAHA-aligned Republicans.
The MAHA movement has been spearheaded by Health and Human Services Secretary Robert F. Kennedy Jr. Its members are largely skeptical of big business, including Big Pharma, Big Ag and Big Chemical — breaking with other Republicans who are often big business allies.
While the measure applies to pesticides broadly, the issue is often talked about in terms of glyphosate, which has been a key ingredient in the weedkiller Roundup.
While the EPA says there’s “insufficient evidence to conclude that glyphosate plays a role in any human diseases,” multiple lawsuits have claimed otherwise — and have cost Bayer billions of dollars.
The question of whether such lawsuits are preempted under federal law will be reviewed by the Supreme Court this year.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















